Results 51 to 60 of about 172,233 (314)

Opportunities for Improving Anticoagulation Care [PDF]

, 2022
In this thesis, we tried to find opportunities for improving anticoagulation care. Both older (VKAs) and newer (DOACs) anticoagulants have been addressed.
Piersma-Wichers, Margriet, Piersma-Wichers, Margriet; id_orcid   +1 more
core   +1 more source

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion

Thrombosis Journal, 2023
Current clinical practice guidelines lack explicit guidance on the indications and appropriate timing of venous ultrasound (US) in lower extremity deep vein thrombosis (DVT) follow-up. Moreover, abnormal findings reported on venous US in DVT follow-up or
Farooq Akram, Bingwen Eugene Fan, Chuen Wen Tan, Wey Chyi Teoh, Paolo Prandoni, Eng Soo Yap   +5 more
doaj   +1 more source

Factors determining patients’ intentions to use point-of-care testing medical devices for self-monitoring: The case of international normalised ratio self-testing

, 2012
This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. - Copyright @ 2012 Dove Medical Press LtdThis article has been made available through the Brunel Open Access Publishing Fund ...
Kuljis, J, Shah, SGS, Barnett, J, Hone, K, Kaczmarski, R   +4 more
core   +1 more source

Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin, Tianyuan Yang, Minglei Liu, Haiyang Luo, Jing Yuan, Ke Zhang, Xinsheng Han, Jing Yang, Yuming Xu   +8 more
wiley   +1 more source

Anticoagulation in cirrhosis [PDF]

Liver International, 2012
The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire   +3 more sources

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli, Cecilia Nalli, Francesca Crisafulli, Carlo Garaffoni, Marcello Govoni, Giulia Voltarel, Alba C. Pozzi, Beatrice Maranini, Ettore Silvagni, Alessandra Bortoluzzi, Angela Tincani   +10 more
wiley   +1 more source

A cross-sectional study of appropriateness evaluation of anticoagulation therapy for inpatients with nonvalvular atrial fibrillation

Frontiers in Pharmacology, 2023
Background: Oral anticoagulants (OACs) are essential for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF). However, the appropriateness of anticoagulation treatment in locally practice remains unclear.
Xiao-Yuan Zheng, Guang-Wei Feng, Jing Guo, Fen Xie, Xia Li, Ming-Zhu Zhang, Ming-Zhu Zhang, Xiu-Fen Zhang, Xiu-Feng Wu, Yong-Juan Ding   +9 more
doaj   +1 more source

Guidelines for anticoagulation [PDF]

BMJ, 1994
EDITOR, - We previously reported an audit of anticoagulant treatment in 100 inpatients with thromboembolic disease.1 Review of the case notes showed incomplete adherence to hospital guidelines on anticoagulant treatment, suggesting that junior doctors either were unaware of the guidelines or found them inaccessible.
F, Taylor, M, Ramsay, A, Renton, H, Cohen   +3 more
openaire   +2 more sources

Necrotizing Pancreatitis: To Anticoagulate or Not to Anticoagulate?

Cureus, 2022
Necrotizing pancreatitis is an inflammatory process that poses a strong risk of systemic venous thromboembolism. However, it is often challenging to opt for systemic anticoagulation since the disease is also associated with an increased risk of hemorrhage.
Abi-Saleh, Simon P, Miller, Ethan A, Magge, Anil, Perez, Mario   +3 more
openaire   +2 more sources